CN Patent

CN1303066C — 2－氧代－1－吡咯烷衍生物、其制备方法和用途

Assigned to UCB SA · Expires 2007-03-07 · 19y expired

What this patent protects

本发明涉及化合物(2S)-2-[4-(2，2-二氟乙烯基)-2-氧代吡咯烷-1-基]丁酸。本发明的化合物特别适用于治疗神经性疾病例如癫痫。

USPTO Abstract

本发明涉及化合物(2S)-2-[4-(2，2-二氟乙烯基)-2-氧代吡咯烷-1-基]丁酸。本发明的化合物特别适用于治疗神经性疾病例如癫痫。

Drugs covered by this patent

Briviact (BRIVARACETAM) · UCB

Patent Metadata

Patent number: CN1303066C
Jurisdiction: CN
Classification: —
Expires: 2007-03-07
Drug substance claim: No
Drug product claim: No
Assignee: UCB SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.